Jan 16 (Reuters) - Htg Molecular Diagnostics Inc:
* HTG MOLECULAR DIAGNOSTICS SAYS BASED ON CURRENTLY AVAILABLE INFORMATION EXPECTS Q4 2017 REVENUE BETWEEN $7.6 MILLION AND $7.9 MILLION - SEC FILING Source text: ( bit.ly/2D99dyn ) Further company coverage:
 